In the kidney, VHL is presumed as an early tumor suppressor gene where genetic and epigenetic events (either by mutation, loss of heterozygosity or hypermethylation of the promoter) are required for tumorigenesis and it has been documented in up to 80% of the sporadic ccRCC [12]. The gene discussed is VHL; the disease is neoplasm.